EDGAR Filing Documents for 0001193125-15-138337

Form 8-K - Current report:

SEC Accession No. 0001193125-15-138337

Filing Date

2015-04-20

Accepted

2015-04-20 17:01:33

Documents

Period of Report

2015-04-15

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d911424d8k.htm	8-K	15532
2	EX-99.1	d911424dex991.htm	EX-99.1	8126
3	EX-99.2	d911424dex992.htm	EX-99.2	8491
4	GRAPHIC	g911424sagent_logo.jpg	GRAPHIC	10256
	Complete submission text file	0001193125-15-138337.txt		47862

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 15781177
SIC: 2834 Pharmaceutical Preparations